Other News To Note
Monday, September 10, 2012
Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., inked a strategic development and investment agreement with Professional Compounding Centers of America Inc. (PCCA), of Houston, which also made a $4 million equity investment through a private transaction.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.